The genome-wide associated studies (GWAS) of AD reveal several genetic risk factors in AD development, in which variants of TREM2 have been found to increase AD risk 2–4 folds, similar to the risk of patients with one copy of ApoE4 [94]. This evidence concerns the gene TREM2 and Alzheimer disease.